top of page
my pic.jpg

Drucker's Lab

Meir Medical Center and Department of Pathology, Sackler Faculty of Medicine, TAU

Our mission

Our research group studies human cancer with emphasis on the malignant cells' interaction with their microenvironment. We aim to characterize the crosstalk between multiple myeloma cells and the bone marrow mesenchymal stem cells that surround them. It is our purpose to identify niche biomarkers for myeloma progression and  new therapeutic targets. On this quest, we make a point to strive for excellence and knowledge persistently and enjoy the journey.

MSCs flur.png
fat.png
ecm.png
mvs.png
mvs uptake.png
mito uptake.png

Latest Publication

Multiple myeloma

BM-MSCs increase tumorgenicity of MM cells via transfer of VLA4-enriched microvesicles

In this study Mahmoud Dabbah showed as part of his Ph.D. thesis that microvesicles derived from BM-MSCs of MM patients promote the disease and can be selectively inhibited from entering the MM cells by targeting the membranal VLA4 

News and Updates

Meir Medical Center Annual Meeting 2020

zoom meeting.png

Excellent study

Composition of bone marrow mesenchymal stem cells' extracellular matrix as a therapeutic target in multiple myeloma

M Zoabi, M Lishner, M Pasmanik-Chor, Y S Brin, S Tartakover-Matalon, O Jarchowsky-Dolberg, L Drucker

Contact
bottom of page